BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Cervical cancer AND PMS2, HNPCC4, 5395, ENSG00000122512, H_DJ0042M02_9, PMSL2, PMS2CL AND Clinical Outcome
9 results:

  • 1. Diffusion basis spectrum imaging predicts long-term clinical outcomes following surgery in cervical spondylotic myelopathy.
    Zhang JK; Jayasekera D; Javeed S; Greenberg JK; Blum J; Dibble CF; Sun P; Song SK; Ray WZ
    Spine J; 2023 Apr; 23(4):504-512. PubMed ID: 36509379
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Chemoradiotherapy response prediction model by proteomic expressional profiling in patients with locally advanced cervical cancer.
    Choi CH; Chung JY; Kang JH; Paik ES; Lee YY; Park W; Byeon SJ; Chung EJ; Kim BG; Hewitt SM; Bae DS
    Gynecol Oncol; 2020 May; 157(2):437-443. PubMed ID: 32107047
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Automated telephone communication systems for preventive healthcare and management of long-term conditions.
    Posadzki P; Mastellos N; Ryan R; Gunn LH; Felix LM; Pappas Y; Gagnon MP; Julious SA; Xiang L; Oldenburg B; Car J
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD009921. PubMed ID: 27960229
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Prognostic relevance of carbonic anhydrase-IX in high-risk, early-stage cervical cancer: a Gynecologic Oncology Group study.
    Liao SY; Darcy KM; Randall LM; Tian C; Monk BJ; Burger RA; Fruehauf JP; Peters WA; Stock RJ; Stanbridge EJ
    Gynecol Oncol; 2010 Mar; 116(3):452-8. PubMed ID: 19913895
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Predicting control of primary tumor and survival by DCE MRI during early therapy in cervical cancer.
    Yuh WT; Mayr NA; Jarjoura D; Wu D; Grecula JC; Lo SS; Edwards SM; Magnotta VA; Sammet S; Zhang H; Montebello JF; Fowler J; Knopp MV; Wang JZ
    Invest Radiol; 2009 Jun; 44(6):343-50. PubMed ID: 19661844
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Concurrent 5-fluorouracil, mitomycin C and radiation with or without brachytherapy in recurrent cervical cancer: a scoring system to predict clinical response and outcome.
    Smaniotto D; D'Agostino G; Luzi S; Valentini V; Macchia G; Mantini G; Margariti PA; Ferrandina G; Scambia G
    Tumori; 2005; 91(4):295-301. PubMed ID: 16277092
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Immunohistochemical analysis of nm23-H1 expression in human cervical lesions.
    Ravazoula P; Aletra C; Kourounis G; Ladopoulos I; Tzigounis V
    Eur J Gynaecol Oncol; 2000; 21(5):510-2. PubMed ID: 11198046
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Tumor proliferation and apoptosis in human uterine cervix carcinoma I: correlations between variables.
    Tsang RW; Fyles AW; Li Y; Rajaraman MM; Chapman W; Pintilie M; Wong CS
    Radiother Oncol; 1999 Jan; 50(1):85-92. PubMed ID: 10225561
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer.
    Burger RA; Monk BJ; Kurosaki T; Anton-Culver H; Vasilev SA; Berman ML; Wilczynski SP
    J Natl Cancer Inst; 1996 Oct; 88(19):1361-8. PubMed ID: 8827013
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.